Procleix ArboPlex Assay is commercially available in CE mark countries!

Grifols is excited to announce the commercial launch of the new Procleix ArboPlex Assay in CE mark countries, the first and only automated nucleic acid test (NAT) system specifically validated for screening blood donors to detect four major arboviruses.

The Procleix ArboPlex Assay tests for four arboviruses: chikungunya virus RNA, dengue virus RNA, West Nile virus RNA and Zika virus RNA. Currently, the risk for arboviruses in blood donors is evaluated either with a monoplex test, duplex test or through using a questionnaire in which donors who declare having traveled to or prior residence in arbovirus-endemic areas are temporarily deferred.

Knowing that the geographic spread and growing exposure to arboviruses is becoming a major public health concern, we designed the Procleix ArboPlex Assay with a 4-in-1 test feature that will make it easier for blood banks and collection centers to more efficiently screen samples, potentially cutting down on the number of deferrals.

With a commitment to supporting the safety of the world’s blood supply, the Procleix ArboPlex Assay is now available in all countries accepting the CE mark certification.